gamma-aminobutyric acid has been researched along with Brain Vascular Disorders in 36 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The therapeutic efficacy of GABA was compared with pyrithioxine and placebo in 432 patients with cerebrovascular disorders by a multi-center (50 hospitals) double-blind clinical trial." | 9.05 | Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. ( Araki, G; Kurihara, M; Mori, A; Otomo, E, 1981) |
| "GABA and Piracetam caused the improvement of the morphological state of cerebral infarction, due to intracarotid infusion of Arachidonic acid." | 7.68 | [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders]. ( Amroian, EA; Balian, LS; Parsamian, LK; Vartazarian, ND, 1990) |
| "The therapeutic efficacy of GABA was compared with pyrithioxine and placebo in 432 patients with cerebrovascular disorders by a multi-center (50 hospitals) double-blind clinical trial." | 5.05 | Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. ( Araki, G; Kurihara, M; Mori, A; Otomo, E, 1981) |
| "GABA and Piracetam caused the improvement of the morphological state of cerebral infarction, due to intracarotid infusion of Arachidonic acid." | 3.68 | [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders]. ( Amroian, EA; Balian, LS; Parsamian, LK; Vartazarian, ND, 1990) |
| " Individualization of dosage and avoidance of unnecessary polypharmacy are essential for safe utilization of anti-epileptic drugs." | 2.44 | [Epilepsy in the elderly]. ( Yoshino, A, 2007) |
| "Although epilepsy was believed to have the highest incidence in childhood, recent epidemiologic studies revealed that the incidence increases markedly in elderly." | 2.44 | [Epilepsy in the elderly]. ( Yoshino, A, 2007) |
| " The dose-response curve of ifenprodil tartrate was shifted to the left by pre-incubation in calcium hopantenate." | 1.27 | A possible mechanism on the potentiating vascular effect of coadministration of ifenprodil tartrate and calcium hopantenate: a study in the internal carotid artery. ( Honda, H; Irino, O; Iwata, T; Izumisawa, M; Matsuda, H; Shibuya, T; Shimura, H; Tsuji, H; Watanabe, Y, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (80.56) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 2 (5.56) | 29.6817 |
| 2010's | 1 (2.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Volotova, EV | 1 |
| Kurkin, DV | 1 |
| Mazina, NV | 1 |
| Berestovitskaia, VM | 1 |
| Vasil'eva, OS | 1 |
| Mikhaĭlova, NA | 1 |
| Kamchatov, PR | 1 |
| HIRAKI, K | 1 |
| IRINO, S | 1 |
| ASANO, T | 1 |
| YAMAMOTO, S | 1 |
| HARAOKA, T | 1 |
| HASHIMOTO, Y | 1 |
| MURAKAMI, B | 1 |
| Yoshino, A | 1 |
| Weinberger, J | 1 |
| Cohen, G | 1 |
| Hall, ED | 1 |
| Becker, RE | 1 |
| Lal, H | 1 |
| Jellinger, K | 1 |
| Riederer, P | 1 |
| Ohtomo, E | 1 |
| Otomo, E | 1 |
| Araki, G | 1 |
| Mori, A | 1 |
| Kurihara, M | 1 |
| Eninia, GI | 1 |
| Smeltere, ES | 1 |
| Godlevska, MA | 1 |
| Uzulinia, IP | 1 |
| Stahl, JS | 1 |
| Rottach, KG | 1 |
| Averbuch-Heller, L | 1 |
| von Maydell, RD | 1 |
| Collins, SD | 1 |
| Leigh, RJ | 1 |
| Ishihara, N | 1 |
| Gotoh, F | 1 |
| Achar, VS | 2 |
| Welch, KM | 2 |
| Chabi, E | 2 |
| Bartosh, K | 1 |
| Meyer, JS | 1 |
| Nell, JH | 1 |
| Nartosh, K | 1 |
| Chee, AN | 1 |
| Mathew, NT | 1 |
| Symon, L | 1 |
| Branston, NM | 1 |
| Strong, AJ | 1 |
| Hope, TD | 1 |
| Mirzoian, SA | 1 |
| Akopian, VP | 1 |
| Mankovskiĭ, NB | 1 |
| Kostiuchenko, VG | 1 |
| Penek, NV | 1 |
| Lukashevich, LP | 1 |
| Samosiuk, IZ | 1 |
| Filonchik, AA | 1 |
| Amroian, EA | 1 |
| Vartazarian, ND | 1 |
| Parsamian, LK | 1 |
| Balian, LS | 1 |
| Schallert, T | 1 |
| Jones, TA | 1 |
| Lindner, MD | 1 |
| Yano, S | 1 |
| Mizuno, M | 1 |
| Watanabe, K | 1 |
| Bruhn, H | 1 |
| Frahm, J | 1 |
| Gyngell, ML | 1 |
| Merboldt, KD | 1 |
| Hänicke, W | 1 |
| Sauter, R | 1 |
| Hashimoto, T | 1 |
| Kimori, M | 1 |
| Nakamura, Y | 1 |
| Kuriyama, K | 1 |
| Hirai, S | 1 |
| Palmer, GC | 1 |
| Jones, EG | 1 |
| Bando, K | 1 |
| Hatanaka, Y | 1 |
| Ohbayashi, S | 1 |
| Irino, O | 2 |
| Shibuya, T | 1 |
| Honda, H | 1 |
| Watanabe, Y | 1 |
| Shimura, H | 1 |
| Matsuda, H | 1 |
| Tsuji, H | 1 |
| Izumisawa, M | 1 |
| Iwata, T | 1 |
| Zinchenko, VA | 2 |
| Popov, EA | 1 |
| Kalinichev, SN | 1 |
| Lobzhanidze, PV | 1 |
| Gottlieb, D | 1 |
| Shahin, D | 1 |
| Palaguta, VD | 1 |
| Sytinskiĭ, IA | 1 |
| Melanich, NN | 1 |
| Tsyrul'nikova, LG | 1 |
| Pigarev, VA | 1 |
| Borromei, A | 1 |
9 reviews available for gamma-aminobutyric acid and Brain Vascular Disorders
| Article | Year |
|---|---|
[Epilepsy in the elderly].
Topics: Aged; Aged, 80 and over; Aging; Amines; Anticonvulsants; Cerebrovascular Disorders; Comorbidity; Cyc | 2007 |
Glucocorticoid effects on central nervous excitability and synaptic transmission.
Topics: Acetylcholine; Animals; Biomechanical Phenomena; Brain; Cats; Cell Membrane; Central Nervous System; | 1982 |
Pharmacological approaches to treatment of hemiballism and hemichorea.
Topics: Acetylcholine; Antipsychotic Agents; Basal Ganglia; Cerebrovascular Disorders; Chorea; Diazepam; Dop | 1983 |
[Recent advances in brain metabolic activators].
Topics: Aged; Amantadine; Animals; Brain; Cats; Cerebrovascular Circulation; Cerebrovascular Disorders; Clin | 1984 |
[Cerebral metabolic activator (author's transl)].
Topics: Adenosine Triphosphate; Animals; Barbiturates; Biogenic Amines; Biotransformation; Brain; Brain Isch | 1979 |
Multilevel transneuronal degeneration after brain damage. Behavioral events and effects of anticonvulsant gamma-aminobutyric acid-related drugs.
Topics: Animals; Atrophy; Behavior, Animal; Cerebrovascular Disorders; Corpus Striatum; Diazepam; gamma-Amin | 1990 |
Cyclic nucleotides in stroke and related cerebrovascular disorders.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine; Adenylyl Cyclas | 1985 |
Neurotransmitters in the cerebral cortex.
Topics: Acetylcholine; Alzheimer Disease; Animals; Cerebral Cortex; Cerebrovascular Disorders; Dementia; Dop | 1986 |
[Some therapeutic effects of GABA in neurology (author's transl)].
Topics: Aminobutyrates; Brain; Brain Diseases; Brain Injuries; Cerebrovascular Disorders; Coma; Epilepsy; ga | 1974 |
2 trials available for gamma-aminobutyric acid and Brain Vascular Disorders
| Article | Year |
|---|---|
[Recent advances in brain metabolic activators].
Topics: Aged; Amantadine; Animals; Brain; Cats; Cerebrovascular Circulation; Cerebrovascular Disorders; Clin | 1984 |
Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Electroencephalograp | 1981 |
26 other studies available for gamma-aminobutyric acid and Brain Vascular Disorders
| Article | Year |
|---|---|
[Comparative analysis of action of beta-phenyl derivatives of glutamic and gamma-aminobutyric acid on cerebral blood flow and cerebrovascular endothelium after irreversible occlusion of the common carotid artery].
Topics: Animals; Blood Flow Velocity; Brain; Carotid Artery, Common; Cerebrovascular Disorders; Endothelium, | 2013 |
[The use of pantogam in patients with moderate cognitive disorders of vascular genesis].
Topics: Aged; Cerebrovascular Disorders; Cognition Disorders; Female; gamma-Aminobutyric Acid; Humans; Male; | 2009 |
[Experience in the use of gamma-aminobutyric acid in our clinic].
Topics: Ambulatory Care Facilities; Amino Acids; Antifibrinolytic Agents; Cerebrovascular Disorders; gamma-A | 1962 |
[On the therapeutic effectiveness of gamma-aminobutyric acid and gamma-amino-beta-hydroxybutyric acid for cerebrovascular disorders and hypertension].
Topics: Amino Acids; Antifibrinolytic Agents; Cerebrovascular Disorders; gamma-Aminobutyric Acid; Hypertensi | 1962 |
[Some experiences with the use of gamma-aminobutyric acid (GABA), especially in cases of coma and disorders caused by disturbances of cerebral circulation].
Topics: Amino Acids; Cerebrovascular Circulation; Cerebrovascular Disorders; Coma; Electroconvulsive Therapy | 1961 |
The differential effect of ischemia on the active uptake of dopamine, gamma-aminobutyric acid, and glutamate by brain synaptosomes.
Topics: Animals; Brain; Brain Ischemia; Carotid Arteries; Cerebrovascular Disorders; Dopamine; gamma-Aminobu | 1982 |
[Central neurotransmitters in cerebral ischemia and stroke].
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Infarction; Cerebrovascular Diso | 1983 |
[Effect of gamma-aminobutyric acid preparations on cerebral circulation in chronic cerebrovascular insufficiency].
Topics: Blood Pressure; Brachial Artery; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Dis | 1982 |
A pilot study of gabapentin as treatment for acquired nystagmus.
Topics: Acetates; Adult; Amines; Anticonvulsants; Brain Stem; Cerebrovascular Disorders; Cyclohexanecarboxyl | 1996 |
Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.
Topics: Aminobutyrates; Cerebrovascular Disorders; Dementia; Epilepsy, Post-Traumatic; Epilepsy, Temporal Lo | 1976 |
Biochemical comparison of migraine and stroke.
Topics: Aminobutyrates; Cerebrovascular Disorders; Cyclic AMP; gamma-Aminobutyric Acid; Humans; Migraine Dis | 1976 |
The concepts of thresholds of ischaemia in relation to brain structure and function.
Topics: Animals; Cell Membrane; Cerebral Cortex; Cerebrovascular Disorders; Disease Models, Animal; Evoked P | 1977 |
[GABA system as a factor facilitating the development of compensation of disordered cerebral hemodynamics].
Topics: Adaptation, Physiological; Aminobutyrates; Animals; Brain; Cats; Cerebrovascular Disorders; Dogs; ga | 1978 |
[Effectiveness of gammalon and anticholinesterase preparations in the restorative and residual periods of ischemic stroke in old age].
Topics: Age Factors; Aged; Aminobutyrates; Cerebrovascular Disorders; Drug Evaluation; Female; Galantamine; | 1976 |
[Use of certain preparations of gamma-aminobutyric acid in diseases of the nervous system].
Topics: Adolescent; Adult; Aged; Aminobutyrates; Brain Injuries; Cerebrovascular Disorders; Child; Drug Eval | 1975 |
[Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Brain; Cerebral Infarction; Cerebrovascular Disorders; | 1990 |
Stimulatory effect of some therapeutic drugs used for improving cerebral insufficiency on gastric acid secretion in rats.
Topics: Animals; Atropine; Baclofen; Carbachol; Cerebrovascular Disorders; Cytidine Diphosphate Choline; gam | 1990 |
Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy.
Topics: Adult; Aspartic Acid; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders; gamma-A | 1989 |
Effect of NC-1100 [1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl) ethanol dihydrochloride] on gamma-aminobutyric acid (GABA) metabolism in rat brain: analysis using stroke-prone spontaneously hypertensive rat.
Topics: 4-Aminobutyrate Transaminase; Amino Acids; Animals; Brain; Cerebrovascular Disorders; gamma-Aminobut | 1989 |
[Agents to improve cerebrovascular circulation and cerebral metabolism--general concepts and classification of the drugs].
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Brain; Cerebrovascul | 1985 |
[A quantitative measurement of the cerebral infarct focus induced by arachidonate infusion and the relationship between measured values and stroke signs].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Brain; Cerebral Infarction; Cerebrovascular Disorders; | 1988 |
A possible mechanism on the potentiating vascular effect of coadministration of ifenprodil tartrate and calcium hopantenate: a study in the internal carotid artery.
Topics: Animals; Blood Flow Velocity; Calcium; Carotid Artery, Internal; Cerebrovascular Disorders; Dogs; Dr | 1988 |
[Use of pikamilon in the combined treatment of patients with cerebral circulatory disorders].
Topics: Adult; Aged; Brain; Cerebrovascular Disorders; Combined Modality Therapy; Drug Combinations; Drug Ev | 1988 |
[Hemiballism and its treatment].
Topics: Cerebrovascular Disorders; Dopamine Antagonists; gamma-Aminobutyric Acid; Humans; Movement Disorders | 1987 |
[Nootropic drugs in the acute period of cerebral stroke].
Topics: Acute Disease; Cerebrovascular Disorders; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans | 1985 |
[Blood serotonin during gammalon treatment of patients with acute cerebrovascular disorders].
Topics: Acute Disease; Adult; Aged; Aminobutyrates; Cerebrovascular Disorders; Female; gamma-Aminobutyric Ac | 1974 |